References
- Yan Y, Liang H, Li T, et al. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis. Leuk Lymphoma 2014 Feb 4. [Epub ahead of print].
- Li C, Liu Y, Hu Z, et al. Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis. Leuk Lymphoma 2013 Oct 24. [Epub ahead of print]
- Liu L, Yang L, Mi Y, et al. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFbeta-MYH11(+) acute myeloid leukemia. Leuk Res 2011; 35:1020–1026.